Anti-Vegf With 3-Week Intervals Is Effective on Anemia in a Patient With Severe Hereditary Hemorrhagic Telangiectasia
Annals of Hematology - Germany
doi 10.1007/s00277-010-1063-5
Full Text
Open PDFAbstract
Available in full text
Date
September 8, 2010
Authors
Publisher
Springer Science and Business Media LLC